Functional characterization of arylsulfatase B mutations in Indian patients with Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI)

被引:2
作者
Uttarilli, Anusha [1 ,2 ]
Pasumarthi, Divya [1 ]
Ranganath, Prajnya [1 ,3 ]
Dalal, Ashwin B. [1 ]
机构
[1] Ctr DNA Fingerprinting & Diagnost, Div Diagnost, 4-1-714 Tuljaguda Complex,Mozamzahi Rd, Hyderabad 500001, Telangana, India
[2] Manipal Univ, Grad Studies, Manipal, Karnataka, India
[3] Nizams Inst Med Sci, Dept Med Genet, Hyderabad, Telangana, India
关键词
Molecular analysis; Mucopolysaccharidoses type VI; Novel mutation; Functional characterization; Pathogenic variant; Genotype-phenotype correlation; MISSENSE MUTATIONS; GENE; ARSB; N-ACETYLGALACTOSAMINE-4-SULFATASE; IDENTIFICATION; MUTANT;
D O I
10.1016/j.gene.2016.11.005
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
MPS VI is an autosomal recessive disorder which occurs due to the deficiency of N-acetyl galactosamine-4-sulfatase (Arylsulfatase B - ARSB) involved in catabolism of dermatan sulfate resulting from disease-causing variations in the ARSB gene. Human Gene Mutation Database (HGMD) search revealed 200 different mutations in ARSB worldwide. In the present study we carried out molecular and functional analyses to characterize the mutations reported by us in Indian population. Mutation analysis of 19 MPS VI patients revealed presence of a total of 15 different mutations of which twelve were novel [p.Asp53Asn (c.157G>A; p.D53N), p.Leu98Arg (c.293T>G; p.L98R), p.Tyr103Serfs*9 (c.306_312delCTACCAG+146del; p.Y103Sfs*9), p.Phe166Leufs*18 (c.496delT; p.F166Lfs*18), p.Ile220Serfs*5 (c.659_660delTA; p.I220Sfs*5), p.Ile350Phe (c.1048A>T; p.I350F), p.Trp353* (c.1059G>A; p.W353*), p.His393Arg (c.1178A>G; p.H393R), p.Ser403Tyrfs* (c.1208delC; p.S403Yfs*), p.Pro445Leu (c.1334C>T; p.P445L), p.Trp450Leu (c.1349G>T; p.W450L) and p.Trp450Cys (c.1350G>C; p.W450C)] and three were known mutations [p.Asp54Asn (c.160G>A; p.D54N), p.Ala237Asp (c.710C>A; p.A237D) and p.Ser320Arg (c.960C>G; p.S320R)]. Functional characterization using site-directed mutagenesis followed by cell transfection assays, immunoblot, reverse transcriptase PCR and immunofluorescence studies for the putative pathogenic variants detected in our MPS VI patient cohort helped us to confirm the pathogenic potential of the variants in ARSB. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:19 / 27
页数:9
相关论文
共 24 条
  • [21] Clinical characteristics of adults with slowly progressing mucopolysaccharidosis VI: a case series
    Thuemler, Anke
    Miebach, Elke
    Lampe, Christina
    Pitz, Susanne
    Kamin, Wolfgang
    Kampmann, Christoph
    Link, Bianca
    Mengel, Eugen
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2012, 35 (06) : 1071 - 1079
  • [22] Novel mutations of the arylsulphatase B (ARSB) gene in Indian patients with mucopolysaccharidosis type VI
    Uttarilli, Anusha
    Ranganath, Prajnya
    Jain, S. Jamal Md Nurul
    Prasad, Krishna C.
    Sinha, Anupam
    Verma, Ishwar C.
    Phadke, Shubha R.
    Puri, Ratna D.
    Danda, Sumita
    Muranjan, Mamta N.
    Jevalikar, Ganesh
    Nagarajaram, H. A.
    Dalal, Ashwin B.
    [J]. INDIAN JOURNAL OF MEDICAL RESEARCH, 2015, 142 : 414 - 425
  • [23] Mucopolysaccharidosis VI
    Valayannopoulos, Vassili
    Nicely, Helen
    Harmatz, Paul
    Turbeville, Sean
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2010, 5
  • [24] Insights into the diagnosis and treatment of lysosomal storage diseases
    Wenger, DA
    Coppola, S
    Liu, SL
    [J]. ARCHIVES OF NEUROLOGY, 2003, 60 (03) : 322 - 328